DAWN (DAY ONE BIOPHARMACEUTICALS I) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold DAWN (DAY ONE BIOPHARMACEUTICALS I) with a combined value of $111.87M across 12,003,377 shares. The largest holder is BlackRock, Inc. with a position worth $82.37M (0.00% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$111.87M
Total Shares Held
12,003,377
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $82.37M | 0.00% | -1.8% |
| 2 | CITADEL ADVISORS LLC | $15.89M | 0.00% | +157.0% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $12.16M | 0.02% | +44.1% |
| 4 | Point72 Asset Management, L.P. | $1.46M | 0.00% | +0.0% |